ABBOTT PARK, Ill., Oct. 21, 2019
/PRNewswire/ -- Abbott (NYSE: ABT) today announced the
Australian Red Cross Blood Service (Australian Blood Service) has
signed a multiple-year agreement for Abbott's most advanced blood
and plasma screening technology, Alinity™ s System. The Australian
Blood Service collects 1.5 million donations each year,
providing a safe blood supply to 25 million Australians.
The agreement also includes Abbott's total lab automation
solution, as well as its informatics and professional services. The
Australian Blood Service staff will use AlinIQ™ AMS (Analyzer
Management System), a product of AlinIQ Professional Services, to
integrate data from multiple analyzers so staff can view it in one
place, providing greater workflow efficiency and better quality
control. The Alinity s system will help continuously process up to
600 tests per hour, while the lab automation solution will manage
routine, manual tasks so staff can handle up to 3,600 samples per
hour.
The adoption of Abbott's latest technologies allows the
Australian Blood Service to bring the highest levels of
efficiency to their operation. By updating Abbott's previous blood
and plasma screening system with Alinity s, and adding total lab
automation to their facilities, the Australian Blood
Service will be able to further improve workflow practices and
productivity.
"For the past 30 years, we've partnered with the
Australian Blood Service to help ensure people in Australia have access to a safe blood supply,"
said Louis Morrone, vice president,
Transfusion Medicine, Abbott. "By combining Abbott's latest
advancements in blood and plasma screening with the benefits of
automation and informatics technology customized to their
organization, the Australian Blood Service can ensure the highest
levels of quality to safeguard their blood supply for years to
come."
About Alinity and AlinIQ
Abbott's Alinity family of
harmonized solutions is unprecedented in the diagnostics and
screening industries. The systems work together to address the
challenges of using multiple testing platforms and simplifying
diagnostic testing and blood and plasma screening. Alinity systems
are designed to be more efficient – running more tests in less
space, generating test results faster and minimizing human errors –
while continuing to provide quality results. The availability of
the Alinity systems and tests varies by geography. More information
is available at abbott.com/alinity.
AlinIQ is a comprehensive offering, combining professional
services and informatics solutions that can assist healthcare
institutions to deliver greater overall productivity and clinical
care efficiency with their existing resources. By taking a
customized approach with each blood and plasma service, Abbott's
professional services experts use proprietary information
technology applications to continuously analyze data and develop
insights that could improve an organization's performance.
About Abbott
Abbott is a global healthcare leader that
helps people live more fully at all stages of life. Our portfolio
of life-changing technologies spans the spectrum of healthcare,
with leading businesses and products in diagnostics, medical
devices, nutritionals and branded generic medicines. Our 103,000
colleagues serve people in more than 160 countries.
Connect with us at www.abbott.com, on LinkedIn at
www.linkedin.com/company/abbott-/, on Facebook
at www.facebook.com/Abbott and on Twitter @AbbottNews and
@AbbottGlobal.
View original
content:http://www.prnewswire.com/news-releases/the-australian-red-cross-blood-service-selects-abbotts-alinity-s-solution-for-blood-and-plasma-screening-300941474.html
SOURCE Abbott